Fucosylated Α1-Acid Glycoprotein as a Biomarker to Predict Prognosis Following Tumor Immunotherapy of Patients With Lung Cancer

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-51021-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

ROR1 Expression as a Biomarker for Predicting Prognosis in Patients With Colorectal Cancer

Oncotarget
Oncology
2017English

Activated Tumor-Infiltrating Fibroblasts Predict Worse Prognosis in Breast Cancer Patients

Journal of Cancer
Oncology
2018English

MiR-205 as a Promising Biomarker in the Diagnosis and Prognosis of Lung Cancer

Oncotarget
Oncology
2017English

ASTHMA AND Α1-Acid GLYCOPROTEIN, HAPTOGLOBIN

Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology
1995English

Tumor Immunity and Autoimmunity Following Cancer Immunotherapy

English

Phosphoglyceric Acid Mutase-1 Contributes to Oncogenic mTOR-mediated Tumor Growth and Confers Non-Small Cell Lung Cancer Patients With Poor Prognosis

Cell Death and Differentiation
Cell BiologyMolecular Biology
2018English

S100B as a Biomarker for Brain Metastases in Patients With Non‑small Cell Lung Cancer

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2020English

Overexpression of HPIP as a Biomarker for Metastasis and Prognosis Prediction in Endometrial Cancer Patients

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2019English

Endometrial Tumor Immune Response: Predictive Biomarker of Response to Immunotherapy

Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy